GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Short-Term Debt

PharmaRoth Labs (PharmaRoth Labs) Short-Term Debt : $0.00 Mil (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Short-Term Debt?

PharmaRoth Labs's Short-Term Debt for the quarter that ended in Mar. 2011 was $0.00 Mil.

PharmaRoth Labs's quarterly Short-Term Debt increased from Sep. 2010 ($0.00 Mil) to Dec. 2010 ($0.25 Mil) but then declined from Dec. 2010 ($0.25 Mil) to Mar. 2011 ($0.00 Mil).


PharmaRoth Labs Short-Term Debt Historical Data

The historical data trend for PharmaRoth Labs's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Short-Term Debt Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Short-Term Debt
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.25 -

PharmaRoth Labs Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


PharmaRoth Labs Short-Term Debt Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines